Mentice

Mentice Assets per Share

The Total Assets per Share of Mentice (MNTC.ST) as of Nov 3, 2026 is 11.09 SEK. In the previous year, Total Assets per Share was 11.51 SEK — a change of -3.67% (lower).

Assets per Share

11.09SEK

YoY

-3.67%

Last updated:

Total Assets per Share of Mentice is 2025 11.09 SEK. Total Assets per Share of Mentice was 2024 11.51 SEK. It decreases by -3.67% lower compared to the previous year.

The Mentice Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
4.64 SEK
Jan 1, 2019
6.65 SEK
Jan 1, 2020
8.72 SEK
Jan 1, 2021
9.31 SEK
Jan 1, 2022
11.84 SEK
Jan 1, 2023
11.47 SEK
Jan 1, 2024
11.51 SEK
Jan 1, 2025
11.09 SEK
The Mentice Assets per Share history
YEARAssets per ShareYoY
11.09SEK-3.67%
11.51SEK+0.43%
11.47SEK-3.14%
11.84SEK+27.14%
9.31SEK+6.78%
8.72SEK+31.06%
6.65SEK+43.31%
4.64SEK+39.19%
3.34SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mentice Stock analysis

What does Mentice do? Mentice AB provides software and hardware simulation solutions for endovascular therapies, targeting healthcare professionals and the medical device industry. The company's solutions are scientifically validated and designed to help users acquire, retain, and enhance procedural skills in neurovascular, cardiovascular, and peripheral interventions. Mentice AB generates revenue through the sale of its simulation products and related services, with key buyers including healthcare providers and medical device manufacturers. The company operates globally, serving clients across multiple healthcare segments that require advanced training tools for minimally invasive procedures. Mentice AB's business model focuses on delivering scientifically validated simulation tools that address skill development needs in complex medical procedures. The firm's product offerings cater to both healthcare institutions seeking to train staff and medical device companies requiring validation tools for their products. By specializing in endovascular therapy simulations, Mentice AB serves a niche market with high demand for precise procedural training solutions. The company's global presence allows it to reach clients in various regions seeking advanced medical simulation technology. The company's revenue streams come from the sale of simulation software and hardware systems alongside ongoing service contracts. Healthcare providers purchase these solutions to improve staff competency in endovascular procedures, while medical device manufacturers use them to validate device performance in simulated environments. Mentice AB's solutions are specifically developed for the medical device industry and healthcare providers, creating a dual revenue stream from both sectors. The firm's focus on scientifically validated tools ensures strong market positioning within specialized medical training segments. Mentice is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mentice stock

Total Assets per Share of Mentice is 11.09 SEK in 2025.

Total Assets per Share of Mentice changed from 11.51 SEK to 11.09 SEK, representing a -3.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Mentice since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Mentice

All Key Metrics — Mentice